2019
DOI: 10.1016/j.pharep.2019.01.011
|View full text |Cite
|
Sign up to set email alerts
|

Teratogenic potential of third-generation antiepileptic drugs: Current status and research needs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 71 publications
0
11
0
Order By: Relevance
“…The greatest concern for WWE is the teratogenicity of AEDs. Accumulating evidence suggests that different AEDs and dosages have different teratogenic risks [23][24][25], and that the newer generation AEDs such as LTG, LEV, and OXC are not associated with significantly increased risks of congenital malformations compared with no AED exposure control [15,16]. In this study, we found that more than 50 % of pregnancies in the unplanned pregnancy group were not prescribed AEDs during pregnancy, which may be because those patients feared drug teratogenicity and had rarely consulted epileptologists before and during pregnancy for relevant knowledge of epilepsy and AED compliance.…”
Section: Discussionmentioning
confidence: 99%
“…The greatest concern for WWE is the teratogenicity of AEDs. Accumulating evidence suggests that different AEDs and dosages have different teratogenic risks [23][24][25], and that the newer generation AEDs such as LTG, LEV, and OXC are not associated with significantly increased risks of congenital malformations compared with no AED exposure control [15,16]. In this study, we found that more than 50 % of pregnancies in the unplanned pregnancy group were not prescribed AEDs during pregnancy, which may be because those patients feared drug teratogenicity and had rarely consulted epileptologists before and during pregnancy for relevant knowledge of epilepsy and AED compliance.…”
Section: Discussionmentioning
confidence: 99%
“…More recently, second-and third-generation anticonvulsants have been developed. Some of these, such as lamotrigine, appear to be less teratogenic (Pariente et al 2017), others are no better than the older drugs (e.g., topiramate; Vajda et al 2019), and comprehensive clinical studies are yet to be completed for others (Singh and Verma 2019). The mechanism by which these drugs affect heart development is not well understood as few animal studies have been carried out.…”
Section: Anticonvulsantsmentioning
confidence: 99%
“…Still, evaluations of tolerability crudely focus on motor toxicity, which itself may poorly correlate with complaints of somnolence or fatigue 65 . Similarly, animal studies on teratogenicity focus primarily on structural malformations, and standardized assessments of neurodevelopmental behavioral toxicity have been consistently deferred and/or ignored 66 . In this study, we asked whether detailed automated evaluations of home-cage behavior would be sensitive enough to detect anticonvulsant psychotropic effects, and further, reveal features of pervasive neurodevelopment (if any) in mice exposed to that anticonvulsant prenatally.…”
Section: Discussionmentioning
confidence: 99%